Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-25-001073
Filing Date
2025-11-17
Accepted
2025-11-17 16:39:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4571
  Complete submission text file 0001968582-25-001073.txt   6060
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Subject) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38599 | Film No.: 251491540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACERAGEN, INC. 15 TW ALEXANDER DRIVE DURHAM NC 27709
Business Address
Kraus Carl N (Reporting) CIK: 0001946475 (see all company filings)

Type: 144